Replimune Group REPL Proceeds From Issuance Of Warrants
Proceeds From Issuance Of Warrants at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfWarrants.
The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Replimune Group's proceeds from issuance of warrants.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Replimune Group's proceeds from issuance of warrants?
- Replimune Group (REPL) reported proceeds from issuance of warrants of $0 in Q4 2025.
- How has Replimune Group's proceeds from issuance of warrants changed year-over-year?
- Replimune Group's proceeds from issuance of warrants decreased by 100.0% year-over-year, from $48.5M to $0.
- What does proceeds from issuance of warrants mean?
- This represents the cash inflows received from the sale or exercise of warrants that grant the holder the right to purchase company stock at a specified price. It serves as a source of capital for the company, often used to fund operations or clinical development. This metric highlights the company's ability to raise equity-linked financing.